Related Experiment Video
Updated: Feb 3, 2026

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
Published on: October 30, 2018
Sirtuin 3 attenuates amyloid-β induced neuronal hypometabolism
Junxiang Yin1, Shiping Li1,2, Megan Nielsen1,3
1Department of Neurology, Barrow Neurological Institute, St. Joseph Hospital and Medical Center, Dignity Health Organization, Phoenix, AZ 85013, USA.
Sirtuin 3 (Sirt3) is crucial for combating Alzheimer's disease (AD) hypometabolism. Boosting Sirt3 levels in brain cells can restore mitochondrial function and energy production, offering a potential therapeutic avenue for AD.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Metabolic Disorders
Background:
- Alzheimer's disease (AD) is characterized by reduced brain metabolism.
- Sirtuin 3 (Sirt3), a mitochondrial protein, regulates cellular metabolism, but its role in AD-related hypometabolism is unclear.
Purpose of the Study:
- To investigate the role of Sirt3 in Alzheimer's disease-associated hypometabolism and amyloid-beta (Aβ) induced mitochondrial dysfunction.
Main Methods:
- Expression profiling and weighted gene co-expression network analysis (WGCNA) in a transgenic AD mouse model (APPSwInd).
- Measurement of NAD+, NAD+/NADH ratio, Sirt3 activity, and ATP production in vivo and in vitro.
- Manipulation of Sirt3 levels (knockdown and overexpression) in hippocampal cells exposed to Aβ.
Main Results:
- WGCNA identified Sirt3 as a key factor in Aβ-related hypometabolism.
- APP mice showed decreased NAD+, NAD+/NADH ratio, Sirt3 activity, and ATP production, correlating with impaired learning and memory.
- Sirt3 overexpression in hippocampal cells rescued Aβ-induced mitochondrial damage and restored ATP production.
Conclusions:
- Sirt3 plays a critical role in regulating cerebral hypometabolism induced by Aβ.
- Modulating Sirt3 activity presents a potential therapeutic strategy for Alzheimer's disease.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
TGF - β Signaling Pathway

